Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KARISMA2: Low-dose Tamoxifen for Breast Cancer Risk Reduction
NCT03346200Phase 2Completed
- Start
- Nov 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tamoxifen in breast cancer. Started Nov 2016; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03346200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03346200.